Questex’s Fierce Biotech and Fierce Pharma have proudly announced the distinguished recipients of the Fierce Life Sciences Innovation Awards for 2023. Recognizing exceptional advancements that are reshaping the life sciences industry, the program emphasizes the profound impact of technology, including artificial intelligence (AI), machine learning, and data collection, across all facets of the sector.
Rebecca Williamson, Senior Vice President, and Publisher of Fierce Biotech and Fierce Pharma, emphasized the significant role of technology in this year’s winners, stating, “This year’s winners reflect the growing impact of technology on our industry – AI, machine learning, and data collection continues to be adopted across every aspect of the industry.” She expressed enthusiasm about showcasing companies at the forefront of innovation, pushing boundaries, and propelling the industry forward.
Offering insights into the industry’s products
Fierce Pharma, a leading source for the latest news, analysis, and data on drugs and the companies that produce them, covers the pharmaceutical landscape comprehensively. From late-stage drug development to the entire lifecycle, Fierce Pharma tracks regulatory approvals, payer negotiations, manufacturing, marketing, patent disputes, government investigations, regulations, mergers and acquisitions, and beyond. The team aims to provide readers with not only what they need to know but also the reasons behind it, offering insights into the industry’s products, finances, and emerging trends through special reports.
Questex, the parent company, is dedicated to improving lives in various sectors, including travel, hospitality, wellness, life science, healthcare, and technology. Connecting people through live events, data insights, and digital communities, Questex delivers experiences and tangible results within the evolving experience economy.
The 2023 Fierce Life Sciences Innovation Awards winners represent diverse categories, showcasing groundbreaking contributions:
- Biotech Innovation: ELEVIDYS (delandistrogene moxeparvovec-rokl) – Sarepta Therapeutics
- Data Analytics/Business Intelligence: BostonGene – AI-based Clinical Trials Matching – BostonGene
- Digital Health Solutions: canturio™te – Canary Medical
- Drug Delivery Technology: RaniPill HC – Rani Therapeutics
- Medical Device Innovation: Nerivio Migraine Neuroband – Theranica Bio-Electronics Ltd
- Technology Innovation: TeleScan®
The winners were meticulously selected by an expert panel of judges who evaluated numerous submissions. These companies demonstrated innovative technologies and services with the potential to make a significant impact on the biotech and pharma industries.
The 2023 Fierce Life Sciences Innovation Awards winners are featured in the Life Sciences Innovation Report, providing an in-depth exploration of their pioneering contributions. Professionals in the biotech industry rely on Fierce Biotech, with over 300,000 top biotech professionals seeking an insider briefing on the day’s top stories.
In celebrating these achievements, the awards highlight the ongoing commitment of the life sciences sector to pushing the boundaries of innovation and driving positive change. Congratulations to the 2023 class of winners for their outstanding contributions to advancing the industry.
Also Read: 6 Innovations in Operative Medicine for Foot and Ankle Surgery
